Annovis Bio (FRA:07X) Accounts Payable & Accrued Expense : €2.32 Mil (As of Mar. 2025)

View and export this data going back to 2020. Start your Free Trial

What is Annovis Bio Accounts Payable & Accrued Expense?

Annovis Bio's quarterly accounts payable & accrued expense declined from Sep. 2024 (€4.86 Mil) to Dec. 2024 (€3.71 Mil) and declined from Dec. 2024 (€3.71 Mil) to Mar. 2025 (€2.32 Mil).

Annovis Bio's annual accounts payable & accrued expense declined from Dec. 2022 (€7.27 Mil) to Dec. 2023 (€3.92 Mil) and declined from Dec. 2023 (€3.92 Mil) to Dec. 2024 (€3.71 Mil).

Annovis Bio Accounts Payable & Accrued Expense Historical Data

The historical data trend for Annovis Bio's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Annovis Bio Accounts Payable & Accrued Expense Chart

Annovis Bio Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

0.48

1.33

7.27

3.92

3.71

Annovis Bio Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															4.48	3.77	4.86	3.71	2.32

Annovis Bio Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Annovis Bio Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Annovis Bio Inc (FRA:07X) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

ANVS:USA

Address

101 Lindenwood Drive, Suite 225, Malvern, PA, USA, 19355

Website

https://www.annovisbio.com

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.

Annovis Bio Headlines

No Headlines